Rapid Ventricular Pacing During Cerebral Aneurysm Surgery: a Retrospective Study Concerning the Safety for Heart and Brain
1 other identifier
observational
27
1 country
1
Brief Summary
Rapid ventricular pacing (RVP) is a technique to obtain flow arrest for short periods of time during dissection or rupture of the aneurysm. RVP results in an adequate fall of blood pressure which presents as an on-off phenomenon. It is not clear whether repetitive periods of pacing are harmless for the patient. Silent cardiac and cerebral infarcts may be undetected. The investigator will study the safety of RVP, particularly for the heart and the brain, retrograde by studying troponin levels and magnetic resonance imaging or computed tomography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 30, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2013
CompletedFirst Submitted
Initial submission to the registry
September 11, 2017
CompletedFirst Posted
Study publicly available on registry
September 13, 2017
CompletedSeptember 13, 2017
September 1, 2017
1.4 years
September 11, 2017
September 11, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Change of cardiac specific enzyme Troponin (cTnl) from preoperative sample (baseline)
For detection of myocardial injury, the cardiac specific enzyme Troponin(cTnl)is evaluated pre-and postoperatively
A first blood sample is collected immediately preoperative in the operating room. Postoperative samples are taken at 24 hours up to 60 hours after start surgery
Secondary Outcomes (1)
Magnetic resonance imaging or computed tomography
Preoperative and within 1 week post surgery
Study Arms (2)
Cerebral aneurysm surgery with RVP
During surgery patients allocated to this group will undergo RVP. Subjects receive Magnetic Resonance Imaging or Computed Tomography as standard of care, pre-and postoperatively. To screen for rapid ventricular pacing induced micro-infarcts, the contralateral hemisphere(contralateral to the hemisphere operated on) and fossa posterior will be evaluated. Troponin levels are determinated preoperatively and 24 hours postoperatively by blood sample as standard of care. Maximum cTnl level and cTnl level 24 hours will be compared.
Craniotomy without RVP
No rapid ventricular pacing is applied during surgery. Subjects receive Magnetic Resonance Imaging or Computed Tomography as standard of care, pre-and postoperatively. To screen for induced micro-infarcts, the contralateral hemisphere(contralateral to the hemisphere operated on) and fossa posterior will be evaluated. Troponin levels are determinated preoperatively and 24 hours postoperatively by blood sample as standard of care. Maximum cTnl level and cTnl level 24 hours will be compared.
Interventions
Rapid ventricular pacing (RVP) is a technique to obtain flow arrest for short period of time during dissection of the aneurysm. RVP results in an adequate fall in blood pressure which presents as an on-off phenomenon. RVP technique facilitates the dissection and manipulation of cerebral aneurysms and arteriovenous malformations and can be lifesaving in the case of an intraoperative bleeding or rupture.
Eligibility Criteria
Patients older than 18 years, schedulled for elective brain surgery and not responding to any of the exclusion criteria
You may qualify if:
- elective cerebral aneurysm clipping surgery
- arteriovenous malformation surgery
- craniotomy
- American Society of Anesthesiologists 1,2 and 3
You may not qualify if:
- cardiac abnormalities
- coronary heart disease
- valvular heart disease
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University hospital Antwerp
Edegem, Antwerp, 2650, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vera Saldien, MD
University Hospital, Antwerp
- PRINCIPAL INVESTIGATOR
Tomas Menovsky, MD, PhD
University Hospital, Antwerp
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- data manager
Study Record Dates
First Submitted
September 11, 2017
First Posted
September 13, 2017
Study Start
August 30, 2011
Primary Completion
January 15, 2013
Study Completion
July 15, 2013
Last Updated
September 13, 2017
Record last verified: 2017-09